What is the registration number for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG?

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG is registered under USPTO registration number 0.

TEC

USPTO Trademark Record

ABANDONED

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG

Q: Who owns the TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark?

The TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark is owned by GENENTECH, INC..

Q: What class is the TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark registered in?

The TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark is registered in Class 044 (Medical, veterinary & beauty care services).

Q: What is the serial number for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG?

The USPTO serial number for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG is 87178937.

SN 87178937·Reg 0·Filed Sep 21, 2016

Owner GENENTECH, INC.

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG (Serial No. 87178937), Registration No. 0, is a abandoned US trademark filed on Sep 21, 2016 by GENENTECH, INC.. This trademark covers Class 044 (Medical, veterinary & beauty care services).

Mark Intelligence

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG (Reg. #0) is an abandoned US trademark that was filed in 2016 but has since been abandoned. The mark covers Class 044 (Medical, veterinary & beauty care services). Goods and services include Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, h.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 21, 2016

SERIAL

87178937

REG#

Owner

Applicant

GENENTECH, INC.

Entity

Corporation

State

Address

1 DNA WAY, SOUTH SAN FRANCISCO, CA, 940804990

Country

Attorney

NameRobin Weatherhead

Docket

TM-40083-US1

Address

1 DNA WAY, SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateSep 21, 2016

Serial Number87178937

Registration No.0

Status DateNov 27, 2020

Published for OppositionApr 03, 2018

Mark TypeDesign with words

Attorney DocketTM-40083-US1

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2016

YEARS AGO

10y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: May 18, 2016

First use in commerce: May 18, 2016

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

53 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 23, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 23, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Apr 23, 2021

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 23, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Nov 27, 2020

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Nov 27, 2020

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

FINAL REFUSAL E-MAILED

May 15, 2020

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

May 15, 2020

NOTIFICATION OF FINAL REFUSAL EMAILED

SU - FINAL REFUSAL - WRITTEN

May 15, 2020

SU - FINAL REFUSAL - WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

May 14, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 13, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 13, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 18, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Nov 18, 2019

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Nov 18, 2019

NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 16, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Nov 16, 2019

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Nov 06, 2019

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Nov 06, 2019

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 08, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 06, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

May 06, 2019

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

May 06, 2019

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 07, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 05, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Nov 05, 2018

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Nov 05, 2018

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 29, 2018

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 03, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Apr 03, 2018

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 14, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 28, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 13, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 13, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Feb 12, 2018

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 05, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Aug 03, 2017

NON-FINAL ACTION WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 03, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Aug 03, 2017

NON-FINAL ACTION E-MAILED

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Aug 02, 2017

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Jul 25, 2017

WITHDRAWN FROM PUB - OG REVIEW QUERY

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 03, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 23, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jun 23, 2017

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jun 23, 2017

EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jun 23, 2017

EXAMINER'S AMENDMENT ENTERED

NON-FINAL ACTION E-MAILED

Jan 04, 2017

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 04, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Jan 04, 2017

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Dec 28, 2016

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 28, 2016

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 27, 2016

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 24, 2016

NEW APPLICATION ENTERED

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by GENENTECH, INC.

Other Marks in Class 044 — Medical, veterinary & beauty care services

Other Marks by Robin Weatherhead

Resources

Company